Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. [electronic resource]
Producer: 19960530Description: 688-93 p. digitalISSN:- 0016-5085
- Adolescent
- Adult
- Aminosalicylic Acids -- therapeutic use
- Anti-Inflammatory Agents -- administration & dosage
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Belgium
- Chi-Square Distribution
- Crohn Disease -- drug therapy
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- France
- Humans
- Logistic Models
- Male
- Mesalamine
- Prednisolone -- administration & dosage
- Proportional Hazards Models
- Recurrence
- Remission Induction
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.